Advertisement

Index by author

January 01, 1992; Volume 41,Issue 1

A

  1. Adham, N

    1. The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor.
      N Adham, P Romanienko, P Hartig, R L Weinshank and T Branchek
      Molecular Pharmacology January 1992, 41 (1) 1-7;

  2. Amiet, R G

    1. In vitro evidence for direct complexation of ADR-529/ICRF-187 [(+)-1,2-bis-(3,5-dioxo-piperazin-1-yl)propane] onto an existing ferric-anthracycline complex.
      M M Sobol, R G Amiet and M D Green
      Molecular Pharmacology January 1992, 41 (1) 8-17;

  3. Anderson, S A

    1. Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor.
      T M Fong, S A Anderson, H Yu, R R Huang and C D Strader
      Molecular Pharmacology January 1992, 41 (1) 24-30;

  4. Andries, K

    1. Allosteric inhibition of human immunodeficiency virus type 1 reverse transcriptase by tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione compounds.
      Z Debyser, R Pauwels, K Andries, J Desmyter, Y Engelborghs, P A Janssen and E De Clercq
      Molecular Pharmacology January 1992, 41 (1) 203-208;

B

  1. Baska, R

    1. Stable expression, secretion, and characterization of active human renin in mammalian cells.
      J A Norman, O Hadjilambris, R Baska, D Y Sharp and R Kumar
      Molecular Pharmacology January 1992, 41 (1) 53-59;

  2. Becker, G W

    1. Two monoclonal antibodies recognizing different epitopes on rat cytochrome IIB1 react with human IIE1.
      S A Wrighton, M Vandenbranden, G W Becker, S D Black and P E Thomas
      Molecular Pharmacology January 1992, 41 (1) 76-82;

  3. Black, S D

    1. Two monoclonal antibodies recognizing different epitopes on rat cytochrome IIB1 react with human IIE1.
      S A Wrighton, M Vandenbranden, G W Becker, S D Black and P E Thomas
      Molecular Pharmacology January 1992, 41 (1) 76-82;

  4. Brach, M A

    1. Activation of the transcription factor kappa B in human KG-1 myeloid leukemia cells treated with 1-beta-D-arabinofuranosylcytosine.
      M A Brach, S M Kharbanda, F Herrmann and D W Kufe
      Molecular Pharmacology January 1992, 41 (1) 60-63;

  5. Branchek, T

    1. The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor.
      N Adham, P Romanienko, P Hartig, R L Weinshank and T Branchek
      Molecular Pharmacology January 1992, 41 (1) 1-7;

  6. Brett, R S

    1. Effects of isoflurane on acetylcholine receptor channels. 1. Single-channel currents.
      J P Dilger, R S Brett and L A Lesko
      Molecular Pharmacology January 1992, 41 (1) 127-133;

  7. Bronson, J J

    1. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
      H T Ho, K L Woods, J J Bronson, H De Boeck, J C Martin and M J Hitchcock
      Molecular Pharmacology January 1992, 41 (1) 197-202;

  8. Burch, R M

    1. 2,6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl] methyl)hexanamide (NPC 15437): a novel inhibitor of protein kinase C interacting at the regulatory domain.
      J P Sullivan, J R Connor, B G Shearer and R M Burch
      Molecular Pharmacology January 1992, 41 (1) 38-44;

  9. Burcher, E

    1. Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung.
      D P Geraghty, C J Mussap and E Burcher
      Molecular Pharmacology January 1992, 41 (1) 147-153;

C

  1. Chao, C C

    1. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
      C C Chao, Y T Huang, C M Ma, W Y Chou and S Lin-Chao
      Molecular Pharmacology January 1992, 41 (1) 69-75;

  2. Chao, E S

    1. Phase II metabolism of warfarin in primary culture of adult rat hepatocytes.
      R L Jansing, E S Chao and L S Kaminsky
      Molecular Pharmacology January 1992, 41 (1) 209-215;

  3. Chou, W Y

    1. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
      C C Chao, Y T Huang, C M Ma, W Y Chou and S Lin-Chao
      Molecular Pharmacology January 1992, 41 (1) 69-75;

  4. Cometta-Morini, C

    1. Molecular determinants of mu receptor recognition for the fentanyl class of compounds.
      C Cometta-Morini, P A Maguire and G H Loew
      Molecular Pharmacology January 1992, 41 (1) 185-196;

  5. Connor, J R

    1. 2,6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl] methyl)hexanamide (NPC 15437): a novel inhibitor of protein kinase C interacting at the regulatory domain.
      J P Sullivan, J R Connor, B G Shearer and R M Burch
      Molecular Pharmacology January 1992, 41 (1) 38-44;

  6. Cote, T E

    1. Angiotensin II receptor recognized by DuP753 regulates two distinct guanine nucleotide-binding protein signaling pathways.
      K W Crawford, E A Frey and T E Cote
      Molecular Pharmacology January 1992, 41 (1) 154-162;

  7. Cotelle, P

    1. Antagonistic effect of a vasoactive intestinal peptide fragment, vasoactive intestinal peptide(1-11), on guinea pig trachea smooth muscle relaxation.
      J F Goossens, N Pommery, M Lohez, J Pommery, N Helbecque, P Cotelle, M Lhermitte and J P Henichart
      Molecular Pharmacology January 1992, 41 (1) 104-109;

  8. Crawford, K W

    1. Angiotensin II receptor recognized by DuP753 regulates two distinct guanine nucleotide-binding protein signaling pathways.
      K W Crawford, E A Frey and T E Cote
      Molecular Pharmacology January 1992, 41 (1) 154-162;

D

  1. Datta, R

    1. Transcriptional and posttranscriptional regulation of H1 histone gene expression by 1-beta-D-arabinofuranosylcytosine.
      R Datta, S Kharbanda and D W Kufe
      Molecular Pharmacology January 1992, 41 (1) 64-68;

  2. De Boeck, H

    1. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
      H T Ho, K L Woods, J J Bronson, H De Boeck, J C Martin and M J Hitchcock
      Molecular Pharmacology January 1992, 41 (1) 197-202;

  3. Debyser, Z

    1. Allosteric inhibition of human immunodeficiency virus type 1 reverse transcriptase by tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione compounds.
      Z Debyser, R Pauwels, K Andries, J Desmyter, Y Engelborghs, P A Janssen and E De Clercq
      Molecular Pharmacology January 1992, 41 (1) 203-208;

  4. De Clercq, E

    1. Allosteric inhibition of human immunodeficiency virus type 1 reverse transcriptase by tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione compounds.
      Z Debyser, R Pauwels, K Andries, J Desmyter, Y Engelborghs, P A Janssen and E De Clercq
      Molecular Pharmacology January 1992, 41 (1) 203-208;

  5. Deery, W J

    1. Carbachol-induced decrease in thyroid cell adenylyl cyclase activity is independent of calcium and phosphodiesterase activation.
      D Pasquali, C S Rani and W J Deery
      Molecular Pharmacology January 1992, 41 (1) 163-167;

  6. Desmyter, J

    1. Allosteric inhibition of human immunodeficiency virus type 1 reverse transcriptase by tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione compounds.
      Z Debyser, R Pauwels, K Andries, J Desmyter, Y Engelborghs, P A Janssen and E De Clercq
      Molecular Pharmacology January 1992, 41 (1) 203-208;

  7. Dilger, J P

    1. Effects of isoflurane on acetylcholine receptor channels. 1. Single-channel currents.
      J P Dilger, R S Brett and L A Lesko
      Molecular Pharmacology January 1992, 41 (1) 127-133;

E

  1. Engelborghs, Y

    1. Allosteric inhibition of human immunodeficiency virus type 1 reverse transcriptase by tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione compounds.
      Z Debyser, R Pauwels, K Andries, J Desmyter, Y Engelborghs, P A Janssen and E De Clercq
      Molecular Pharmacology January 1992, 41 (1) 203-208;

F

  1. Flores, C M

    1. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
      C M Flores, S W Rogers, L A Pabreza, B B Wolfe and K J Kellar
      Molecular Pharmacology January 1992, 41 (1) 31-37;

  2. Fong, T M

    1. Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor.
      T M Fong, S A Anderson, H Yu, R R Huang and C D Strader
      Molecular Pharmacology January 1992, 41 (1) 24-30;

  3. Franklin, P H

    1. High affinity [3H]dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel.
      P H Franklin and T F Murray
      Molecular Pharmacology January 1992, 41 (1) 134-146;

  4. Frey, E A

    1. Angiotensin II receptor recognized by DuP753 regulates two distinct guanine nucleotide-binding protein signaling pathways.
      K W Crawford, E A Frey and T E Cote
      Molecular Pharmacology January 1992, 41 (1) 154-162;

G

  1. Geraghty, D P

    1. Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung.
      D P Geraghty, C J Mussap and E Burcher
      Molecular Pharmacology January 1992, 41 (1) 147-153;

  2. Goossens, J F

    1. Antagonistic effect of a vasoactive intestinal peptide fragment, vasoactive intestinal peptide(1-11), on guinea pig trachea smooth muscle relaxation.
      J F Goossens, N Pommery, M Lohez, J Pommery, N Helbecque, P Cotelle, M Lhermitte and J P Henichart
      Molecular Pharmacology January 1992, 41 (1) 104-109;

  3. Green, M D

    1. In vitro evidence for direct complexation of ADR-529/ICRF-187 [(+)-1,2-bis-(3,5-dioxo-piperazin-1-yl)propane] onto an existing ferric-anthracycline complex.
      M M Sobol, R G Amiet and M D Green
      Molecular Pharmacology January 1992, 41 (1) 8-17;

H

  1. Hadjilambris, O

    1. Stable expression, secretion, and characterization of active human renin in mammalian cells.
      J A Norman, O Hadjilambris, R Baska, D Y Sharp and R Kumar
      Molecular Pharmacology January 1992, 41 (1) 53-59;

  2. Hartig, P

    1. The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor.
      N Adham, P Romanienko, P Hartig, R L Weinshank and T Branchek
      Molecular Pharmacology January 1992, 41 (1) 1-7;

  3. Helbecque, N

    1. Antagonistic effect of a vasoactive intestinal peptide fragment, vasoactive intestinal peptide(1-11), on guinea pig trachea smooth muscle relaxation.
      J F Goossens, N Pommery, M Lohez, J Pommery, N Helbecque, P Cotelle, M Lhermitte and J P Henichart
      Molecular Pharmacology January 1992, 41 (1) 104-109;

  4. Henichart, J P

    1. Antagonistic effect of a vasoactive intestinal peptide fragment, vasoactive intestinal peptide(1-11), on guinea pig trachea smooth muscle relaxation.
      J F Goossens, N Pommery, M Lohez, J Pommery, N Helbecque, P Cotelle, M Lhermitte and J P Henichart
      Molecular Pharmacology January 1992, 41 (1) 104-109;

  5. Herrmann, F

    1. Activation of the transcription factor kappa B in human KG-1 myeloid leukemia cells treated with 1-beta-D-arabinofuranosylcytosine.
      M A Brach, S M Kharbanda, F Herrmann and D W Kufe
      Molecular Pharmacology January 1992, 41 (1) 60-63;

  6. Hitchcock, M J

    1. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
      H T Ho, K L Woods, J J Bronson, H De Boeck, J C Martin and M J Hitchcock
      Molecular Pharmacology January 1992, 41 (1) 197-202;

  7. Ho, H T

    1. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
      H T Ho, K L Woods, J J Bronson, H De Boeck, J C Martin and M J Hitchcock
      Molecular Pharmacology January 1992, 41 (1) 197-202;

  8. Huang, R R

    1. Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor.
      T M Fong, S A Anderson, H Yu, R R Huang and C D Strader
      Molecular Pharmacology January 1992, 41 (1) 24-30;

  9. Huang, Y T

    1. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
      C C Chao, Y T Huang, C M Ma, W Y Chou and S Lin-Chao
      Molecular Pharmacology January 1992, 41 (1) 69-75;

J

  1. Jansing, R L

    1. Phase II metabolism of warfarin in primary culture of adult rat hepatocytes.
      R L Jansing, E S Chao and L S Kaminsky
      Molecular Pharmacology January 1992, 41 (1) 209-215;

  2. Janssen, P A

    1. Allosteric inhibition of human immunodeficiency virus type 1 reverse transcriptase by tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione compounds.
      Z Debyser, R Pauwels, K Andries, J Desmyter, Y Engelborghs, P A Janssen and E De Clercq
      Molecular Pharmacology January 1992, 41 (1) 203-208;

K

  1. Kaminsky, L S

    1. Phase II metabolism of warfarin in primary culture of adult rat hepatocytes.
      R L Jansing, E S Chao and L S Kaminsky
      Molecular Pharmacology January 1992, 41 (1) 209-215;

  2. Kellar, K J

    1. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
      C M Flores, S W Rogers, L A Pabreza, B B Wolfe and K J Kellar
      Molecular Pharmacology January 1992, 41 (1) 31-37;

  3. Kharbanda, S

    1. Transcriptional and posttranscriptional regulation of H1 histone gene expression by 1-beta-D-arabinofuranosylcytosine.
      R Datta, S Kharbanda and D W Kufe
      Molecular Pharmacology January 1992, 41 (1) 64-68;

  4. Kharbanda, S M

    1. Activation of the transcription factor kappa B in human KG-1 myeloid leukemia cells treated with 1-beta-D-arabinofuranosylcytosine.
      M A Brach, S M Kharbanda, F Herrmann and D W Kufe
      Molecular Pharmacology January 1992, 41 (1) 60-63;

  5. Kufe, D W

    1. Activation of the transcription factor kappa B in human KG-1 myeloid leukemia cells treated with 1-beta-D-arabinofuranosylcytosine.
      M A Brach, S M Kharbanda, F Herrmann and D W Kufe
      Molecular Pharmacology January 1992, 41 (1) 60-63;
    2. Transcriptional and posttranscriptional regulation of H1 histone gene expression by 1-beta-D-arabinofuranosylcytosine.
      R Datta, S Kharbanda and D W Kufe
      Molecular Pharmacology January 1992, 41 (1) 64-68;

  6. Kumar, R

    1. Stable expression, secretion, and characterization of active human renin in mammalian cells.
      J A Norman, O Hadjilambris, R Baska, D Y Sharp and R Kumar
      Molecular Pharmacology January 1992, 41 (1) 53-59;

L

  1. Lesko, L A

    1. Effects of isoflurane on acetylcholine receptor channels. 1. Single-channel currents.
      J P Dilger, R S Brett and L A Lesko
      Molecular Pharmacology January 1992, 41 (1) 127-133;

  2. Lhermitte, M

    1. Antagonistic effect of a vasoactive intestinal peptide fragment, vasoactive intestinal peptide(1-11), on guinea pig trachea smooth muscle relaxation.
      J F Goossens, N Pommery, M Lohez, J Pommery, N Helbecque, P Cotelle, M Lhermitte and J P Henichart
      Molecular Pharmacology January 1992, 41 (1) 104-109;

  3. Lin-Chao, S

    1. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
      C C Chao, Y T Huang, C M Ma, W Y Chou and S Lin-Chao
      Molecular Pharmacology January 1992, 41 (1) 69-75;

  4. Loew, G H

    1. Molecular determinants of mu receptor recognition for the fentanyl class of compounds.
      C Cometta-Morini, P A Maguire and G H Loew
      Molecular Pharmacology January 1992, 41 (1) 185-196;

  5. Lohez, M

    1. Antagonistic effect of a vasoactive intestinal peptide fragment, vasoactive intestinal peptide(1-11), on guinea pig trachea smooth muscle relaxation.
      J F Goossens, N Pommery, M Lohez, J Pommery, N Helbecque, P Cotelle, M Lhermitte and J P Henichart
      Molecular Pharmacology January 1992, 41 (1) 104-109;

  6. Lummis, S C

    1. Solubilization, purification, and functional reconstitution of 5-hydroxytryptamine3 receptors from N1E-115 neuroblastoma cells.
      S C Lummis and I L Martin
      Molecular Pharmacology January 1992, 41 (1) 18-23;

M

  1. Ma, C M

    1. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
      C C Chao, Y T Huang, C M Ma, W Y Chou and S Lin-Chao
      Molecular Pharmacology January 1992, 41 (1) 69-75;

  2. Macdonald, R L

    1. The polyamine spermine has multiple actions on N-methyl-D-aspartate receptor single-channel currents in cultured cortical neurons.
      D M Rock and R L Macdonald
      Molecular Pharmacology January 1992, 41 (1) 83-88;

  3. Maguire, P A

    1. Molecular determinants of mu receptor recognition for the fentanyl class of compounds.
      C Cometta-Morini, P A Maguire and G H Loew
      Molecular Pharmacology January 1992, 41 (1) 185-196;

  4. Martin, I L

    1. Solubilization, purification, and functional reconstitution of 5-hydroxytryptamine3 receptors from N1E-115 neuroblastoma cells.
      S C Lummis and I L Martin
      Molecular Pharmacology January 1992, 41 (1) 18-23;

  5. Martin, J C

    1. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
      H T Ho, K L Woods, J J Bronson, H De Boeck, J C Martin and M J Hitchcock
      Molecular Pharmacology January 1992, 41 (1) 197-202;

  6. Miledi, R

    1. Effects of steroids on gamma-aminobutyric acid receptors expressed in Xenopus oocytes by poly(A)+ RNA from mammalian brain and retina.
      R M Woodward, L Polenzani and R Miledi
      Molecular Pharmacology January 1992, 41 (1) 89-103;

  7. Murray, T F

    1. High affinity [3H]dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel.
      P H Franklin and T F Murray
      Molecular Pharmacology January 1992, 41 (1) 134-146;

  8. Mussap, C J

    1. Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung.
      D P Geraghty, C J Mussap and E Burcher
      Molecular Pharmacology January 1992, 41 (1) 147-153;

N

  1. Norman, J A

    1. Stable expression, secretion, and characterization of active human renin in mammalian cells.
      J A Norman, O Hadjilambris, R Baska, D Y Sharp and R Kumar
      Molecular Pharmacology January 1992, 41 (1) 53-59;

  2. Nunn, D L

    1. Luminal Ca2+ increases the sensitivity of Ca2+ stores to inositol 1,4,5-trisphosphate.
      D L Nunn and C W Taylor
      Molecular Pharmacology January 1992, 41 (1) 115-119;

P

  1. Pabreza, L A

    1. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
      C M Flores, S W Rogers, L A Pabreza, B B Wolfe and K J Kellar
      Molecular Pharmacology January 1992, 41 (1) 31-37;

  2. Pasquali, D

    1. Carbachol-induced decrease in thyroid cell adenylyl cyclase activity is independent of calcium and phosphodiesterase activation.
      D Pasquali, C S Rani and W J Deery
      Molecular Pharmacology January 1992, 41 (1) 163-167;

  3. Pauwels, R

    1. Allosteric inhibition of human immunodeficiency virus type 1 reverse transcriptase by tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione compounds.
      Z Debyser, R Pauwels, K Andries, J Desmyter, Y Engelborghs, P A Janssen and E De Clercq
      Molecular Pharmacology January 1992, 41 (1) 203-208;

  4. Polenzani, L

    1. Effects of steroids on gamma-aminobutyric acid receptors expressed in Xenopus oocytes by poly(A)+ RNA from mammalian brain and retina.
      R M Woodward, L Polenzani and R Miledi
      Molecular Pharmacology January 1992, 41 (1) 89-103;

  5. Pommery, J

    1. Antagonistic effect of a vasoactive intestinal peptide fragment, vasoactive intestinal peptide(1-11), on guinea pig trachea smooth muscle relaxation.
      J F Goossens, N Pommery, M Lohez, J Pommery, N Helbecque, P Cotelle, M Lhermitte and J P Henichart
      Molecular Pharmacology January 1992, 41 (1) 104-109;

  6. Pommery, N

    1. Antagonistic effect of a vasoactive intestinal peptide fragment, vasoactive intestinal peptide(1-11), on guinea pig trachea smooth muscle relaxation.
      J F Goossens, N Pommery, M Lohez, J Pommery, N Helbecque, P Cotelle, M Lhermitte and J P Henichart
      Molecular Pharmacology January 1992, 41 (1) 104-109;

  7. Powell, P

    1. Guanylnucleotide specificity for muscarinic receptor inhibitory coupling to cardiac adenylate cyclase.
      E Quist, P Powell and R Vasan
      Molecular Pharmacology January 1992, 41 (1) 177-184;

Q

  1. Quist, E

    1. Regulation of GDP and GTP binding in cardiac sarcolemma by muscarinic receptor agonists.
      E Quist
      Molecular Pharmacology January 1992, 41 (1) 168-176;
    2. Guanylnucleotide specificity for muscarinic receptor inhibitory coupling to cardiac adenylate cyclase.
      E Quist, P Powell and R Vasan
      Molecular Pharmacology January 1992, 41 (1) 177-184;

R

  1. Rani, C S

    1. Carbachol-induced decrease in thyroid cell adenylyl cyclase activity is independent of calcium and phosphodiesterase activation.
      D Pasquali, C S Rani and W J Deery
      Molecular Pharmacology January 1992, 41 (1) 163-167;

  2. Reider, N

    1. Ion dependence of the partially purified mitochondrial dihydropyridine Ca2+ antagonist receptor.
      G Zernig and N Reider
      Molecular Pharmacology January 1992, 41 (1) 45-52;

  3. Rock, D M

    1. The polyamine spermine has multiple actions on N-methyl-D-aspartate receptor single-channel currents in cultured cortical neurons.
      D M Rock and R L Macdonald
      Molecular Pharmacology January 1992, 41 (1) 83-88;

  4. Rogers, S W

    1. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
      C M Flores, S W Rogers, L A Pabreza, B B Wolfe and K J Kellar
      Molecular Pharmacology January 1992, 41 (1) 31-37;

  5. Romanienko, P

    1. The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor.
      N Adham, P Romanienko, P Hartig, R L Weinshank and T Branchek
      Molecular Pharmacology January 1992, 41 (1) 1-7;

S

  1. Salgado, V L

    1. Slow voltage-dependent block of sodium channels in crayfish nerve by dihydropyrazole insecticides.
      V L Salgado
      Molecular Pharmacology January 1992, 41 (1) 120-126;

  2. Sharp, D Y

    1. Stable expression, secretion, and characterization of active human renin in mammalian cells.
      J A Norman, O Hadjilambris, R Baska, D Y Sharp and R Kumar
      Molecular Pharmacology January 1992, 41 (1) 53-59;

  3. Shearer, B G

    1. 2,6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl] methyl)hexanamide (NPC 15437): a novel inhibitor of protein kinase C interacting at the regulatory domain.
      J P Sullivan, J R Connor, B G Shearer and R M Burch
      Molecular Pharmacology January 1992, 41 (1) 38-44;

  4. Sobol, M M

    1. In vitro evidence for direct complexation of ADR-529/ICRF-187 [(+)-1,2-bis-(3,5-dioxo-piperazin-1-yl)propane] onto an existing ferric-anthracycline complex.
      M M Sobol, R G Amiet and M D Green
      Molecular Pharmacology January 1992, 41 (1) 8-17;

  5. Strader, C D

    1. Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor.
      T M Fong, S A Anderson, H Yu, R R Huang and C D Strader
      Molecular Pharmacology January 1992, 41 (1) 24-30;

  6. Sullivan, J P

    1. 2,6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl] methyl)hexanamide (NPC 15437): a novel inhibitor of protein kinase C interacting at the regulatory domain.
      J P Sullivan, J R Connor, B G Shearer and R M Burch
      Molecular Pharmacology January 1992, 41 (1) 38-44;

  7. Swillens, S

    1. Dynamic control of inositol 1,4,5-trisphosphate-induced Ca2+ release: a theoretical explanation for the quantal release of Ca2+.
      S Swillens
      Molecular Pharmacology January 1992, 41 (1) 110-114;

T

  1. Taylor, C W

    1. Luminal Ca2+ increases the sensitivity of Ca2+ stores to inositol 1,4,5-trisphosphate.
      D L Nunn and C W Taylor
      Molecular Pharmacology January 1992, 41 (1) 115-119;

  2. Thomas, P E

    1. Two monoclonal antibodies recognizing different epitopes on rat cytochrome IIB1 react with human IIE1.
      S A Wrighton, M Vandenbranden, G W Becker, S D Black and P E Thomas
      Molecular Pharmacology January 1992, 41 (1) 76-82;

V

  1. Vandenbranden, M

    1. Two monoclonal antibodies recognizing different epitopes on rat cytochrome IIB1 react with human IIE1.
      S A Wrighton, M Vandenbranden, G W Becker, S D Black and P E Thomas
      Molecular Pharmacology January 1992, 41 (1) 76-82;

  2. Vasan, R

    1. Guanylnucleotide specificity for muscarinic receptor inhibitory coupling to cardiac adenylate cyclase.
      E Quist, P Powell and R Vasan
      Molecular Pharmacology January 1992, 41 (1) 177-184;

W

  1. Weinshank, R L

    1. The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor.
      N Adham, P Romanienko, P Hartig, R L Weinshank and T Branchek
      Molecular Pharmacology January 1992, 41 (1) 1-7;

  2. Wolfe, B B

    1. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
      C M Flores, S W Rogers, L A Pabreza, B B Wolfe and K J Kellar
      Molecular Pharmacology January 1992, 41 (1) 31-37;

  3. Woods, K L

    1. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
      H T Ho, K L Woods, J J Bronson, H De Boeck, J C Martin and M J Hitchcock
      Molecular Pharmacology January 1992, 41 (1) 197-202;

  4. Woodward, R M

    1. Effects of steroids on gamma-aminobutyric acid receptors expressed in Xenopus oocytes by poly(A)+ RNA from mammalian brain and retina.
      R M Woodward, L Polenzani and R Miledi
      Molecular Pharmacology January 1992, 41 (1) 89-103;

  5. Wrighton, S A

    1. Two monoclonal antibodies recognizing different epitopes on rat cytochrome IIB1 react with human IIE1.
      S A Wrighton, M Vandenbranden, G W Becker, S D Black and P E Thomas
      Molecular Pharmacology January 1992, 41 (1) 76-82;

Y

  1. Yu, H

    1. Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor.
      T M Fong, S A Anderson, H Yu, R R Huang and C D Strader
      Molecular Pharmacology January 1992, 41 (1) 24-30;

Z

  1. Zernig, G

    1. Ion dependence of the partially purified mitochondrial dihydropyridine Ca2+ antagonist receptor.
      G Zernig and N Reider
      Molecular Pharmacology January 1992, 41 (1) 45-52;
Back to top

In this issue

Advertisement